UNCY Logo.jpg
Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor Conference
May 23, 2024 07:03 ET | Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
Luckin Coffee Inc. Announces Change to Board of Directors
May 23, 2024 07:00 ET | Luckin Coffee Inc.
BEIJING, May 23, 2024 (GLOBE NEWSWIRE) -- Luckin Coffee Inc. (“Luckin Coffee” or the “Company”) (OTC: LKNCY) today announced a change to the Board of Directors (the “Board”). The Board previously...
NEW ATAI-Logo_Primary.png
atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
May 23, 2024 07:00 ET | atai Life Sciences
NEW YORK and BERLIN, May 23, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental...
arcpoint logo.png
ARCPOINT TO HOST CONFERENCE CALL TO DISCUSS 2024 Q1 FINANCIAL RESULTS
May 23, 2024 07:00 ET | ARCpoint Inc.
Greenville, South Carolina, May 23, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) a leading US-based franchise system providing drug testing, alcohol screening,...
Hydreight-02_horizontal-01 (1) (002).jpg
Hydreight Technologies through its associated Medical network now offer Tirzepatide to Product Offering which also features GLP-1 Medications (Low-Cost Semaglutide), NAD+ and more
May 23, 2024 07:00 ET | Hydreight Technologies Inc.
Tirzepatide, a dual GIP and GLP-1 receptor agonist (GIP/GLP-1 RA), is an antidiabetic medication used for the treatment of type 2 diabetes and for weight loss. The GLP-1 segment is an important class...
Logo_Linkedin_1200x627.jpg
Aya Gold & Silver Announces Annual General Meeting
May 23, 2024 07:00 ET | Aya Gold & Silver Inc.
Montreal, Quebec, May 23, 2024 - Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) is pleased to announce the filing of its Management Information Circular.
Unknown.png
TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing
May 23, 2024 07:00 ET | TFF Pharmaceuticals, Inc.
The Leidos team’s Next-Generation Medical Countermeasures (MCMs) Successfully Formulated with Company’s Proprietary Thin Film Freezing Technology MCM Candidates Demonstrated Chemical and Biological...
OTC Markets-News Trading logo.png
OTC Markets Group Welcomes Direct Selling Acquisition Corp. to OTCQX
May 23, 2024 07:00 ET | OTC Markets
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Direct Selling...
Professional headshot of Charles S. Cullum, Chief Financial Officer, Sandy Spring Bank
Sandy Spring Bancorp’s Board of Directors Appoints Charles S. Cullum Chief Financial Officer
May 23, 2024 07:00 ET | Sandy Spring Bancorp, Inc.
OLNEY, Md., May 23, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Sandy Spring Bancorp, Inc. (Nasdaq-SASR), today announced the appointment of Charles S. Cullum to Chief Financial Officer....
TilrayBrands_Logo_FullColor_RBG_Horiz-01.png
Solei Brand Introduces New Cannabis-Infused ‘Warming Deep Tissue Stick’
May 23, 2024 07:00 ET | Tilray Brands, Inc.
TORONTO, May 23, 2024 (GLOBE NEWSWIRE) -- May 23, 2024 – Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company today announces the latest...